HZNP(Delisted)
Horizon Therapeutics Public·NASDAQ
--
--(--)
HZNP fundamentals
Horizon Therapeutics Public (HZNP) released its earnings on Aug 7, 2017: revenue was -- (YoY 0.00%), beat estimates; EPS was -- (YoY 0.00%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
--
0.00%
Report date
Aug 7, 2017
EPS
Revenue
Revenue & Expenses
HZNP has released its 2023 Q2 earnings report, with revenue of 944.96M, reflecting a YoY change of 7.82%, and net profit of 127.07M, showing a YoY change of 108.40%. The Sankey diagram below clearly presents HZNP's revenue sources and cost distribution.
Key Indicators
Horizon Therapeutics Public (HZNP) key financial stats and ratios, covering profitability, financial health, and leverage.
Horizon Therapeutics Public (HZNP)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Horizon Therapeutics Public (HZNP)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Horizon Therapeutics Public (HZNP)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Horizon Therapeutics Public (HZNP) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Horizon Therapeutics Public (HZNP) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
No Data
